Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Todd Conley, Tufts University
ClinicalTrials.gov Identifier:
NCT00795717
First received: November 19, 2008
Last updated: November 17, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
No publications provided by Tufts University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):